• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.

作者信息

Foradori A, Mezzano S, Videla C, Pefaur J, Elberg A

机构信息

Sch. Medicine Catholic University, Santiago, Chile.

出版信息

Transplant Proc. 1998 Aug;30(5):1685-7. doi: 10.1016/s0041-1345(98)00393-5.

DOI:10.1016/s0041-1345(98)00393-5
PMID:9723244
Abstract
摘要

相似文献

1
Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants.
Transplant Proc. 1998 Aug;30(5):1685-7. doi: 10.1016/s0041-1345(98)00393-5.
2
Study of neoral kinetics in adult renal transplantation treated with diltiazem.地尔硫䓬治疗成人肾移植中他克莫司药代动力学的研究。
Transplant Proc. 1998 Aug;30(5):1660-2. doi: 10.1016/s0041-1345(98)00381-9.
3
Conversion from Sandimmune to Neoral in renal transplant: functional histopathological, and pharmacokinetic changes.肾移植中从山地明转换为新山地明：功能、组织病理学及药代动力学变化
Transplant Proc. 1998 Aug;30(5):1756-7. doi: 10.1016/s0041-1345(98)00417-5.
4
A critical appraisal of cyclosporine A pharmacokinetics in pediatric kidney transplantation using a microemulsion galenic formulation (Neoral).
Transplant Proc. 1998 Aug;30(5):1666-7. doi: 10.1016/s0041-1345(98)00384-4.
5
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approach.
Ther Drug Monit. 1998 Aug;20(4):390-5. doi: 10.1097/00007691-199808000-00007.
6
No gender-associated differences of cyclosporine pharmacokinetics in stable renal transplant patients treated with diltiazem.在用硫氮卓酮治疗的稳定肾移植患者中，环孢素的药代动力学不存在性别相关差异。
Transplant Proc. 2005 Oct;37(8):3364-6. doi: 10.1016/j.transproceed.2005.09.098.
7
First-pass metabolism of cyclosporine A in human intestine: inhibition by diltiazem.
Transplant Proc. 1998 Sep;30(6):2545-6. doi: 10.1016/s0041-1345(98)00719-2.
8
Estimated area-under-the-curve monitoring of Neoral in a stable pediatric renal transplant population: one-year experience.
Transplant Proc. 1998 Aug;30(5):1983-4. doi: 10.1016/s0041-1345(98)00504-1.
9
Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors.接受代谢抑制剂的心脏移植受者中环孢素的药代动力学
J Heart Lung Transplant. 2001 Apr;20(4):431-8. doi: 10.1016/s1053-2498(00)00234-5.
10
Conventional versus Neoral cyclosporine in renal transplantation.肾移植中传统环孢素与新山地明的比较
Transplant Proc. 1998 Aug;30(5):1764-5. doi: 10.1016/s0041-1345(98)00421-7.

引用本文的文献

1
Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful.在移植中联合使用细胞色素P-450 3A4调节剂与环孢素或依维莫司是成功的。
World J Transplant. 2015 Dec 24;5(4):338-47. doi: 10.5500/wjt.v5.i4.338.
2
The effects of diltiazem in renal transplantation patients treated with cyclosporine A.地尔硫䓬对接受环孢素A治疗的肾移植患者的影响。
J Biomed Res. 2010 Jul;24(4):317-23. doi: 10.1016/S1674-8301(10)60044-9.
3
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
在中国西北地区的临床肾移植中，采用地尔硫卓联合 CsA/MMF/Pred 或 CsA/Aza/Pred 三联免疫抑制方案进行联合治疗。
Eur J Clin Pharmacol. 2011 Jun;67(6):553-62. doi: 10.1007/s00228-011-0991-x. Epub 2011 Jan 29.
4
A proposal for a pharmacokinetic interaction significance classification system (PISCS) based on predicted drug exposure changes and its potential application to alert classifications in product labelling.基于预测药物暴露变化的药代动力学相互作用显著性分类系统（PISCS）提案及其在产品标签警示分类中的潜在应用。
Clin Pharmacokinet. 2009;48(10):653-66. doi: 10.2165/11317220-000000000-00000.
5
[Drug-drug interactions in urology].[泌尿外科中的药物相互作用]
Urologe A. 2009 Mar;48(3):264-9. doi: 10.1007/s00120-008-1914-z.
6
Cyclosporin therapeutic drug monitoring--an established service revisited.环孢素治疗药物监测——对一项成熟服务的重新审视。
Clin Biochem Rev. 2003 May;24(2):33-46.
7
Past, present, and future technologies for oral delivery of therapeutic proteins.用于治疗性蛋白质口服递送的过去、现在和未来技术。
J Pharm Sci. 2008 Jul;97(7):2497-523. doi: 10.1002/jps.21183.
8
General framework for the quantitative prediction of CYP3A4-mediated oral drug interactions based on the AUC increase by coadministration of standard drugs.基于标准药物联合给药后AUC增加的CYP3A4介导的口服药物相互作用定量预测的一般框架。
Clin Pharmacokinet. 2007;46(8):681-96. doi: 10.2165/00003088-200746080-00005.
9
Co-prescription of cytochrome P450 2D6/3A4 inhibitor-substrate pairs in clinical practice. A retrospective analysis of data from Norwegian primary pharmacies.临床实践中细胞色素P450 2D6/3A4抑制剂-底物对的联合处方。挪威初级药房数据的回顾性分析。
Eur J Clin Pharmacol. 2005 Apr;61(2):119-25. doi: 10.1007/s00228-004-0877-2. Epub 2005 Feb 4.
10
The use of a cyclosporin-ketoconazole combination: making renal transplantation affordable in developing countries.环孢素与酮康唑联合使用：使发展中国家的肾移植成为可负担得起的治疗方法。
Eur J Clin Pharmacol. 2004 May;60(3):143-8. doi: 10.1007/s00228-004-0745-0. Epub 2004 Apr 9.